Cytomegalovirus Ventriculoencephalitis after Unrelated Double Cord Blood Stem Cell Transplantation with an Alemtuzumab-containing Preparative Regimen for Philadelphia-positive Acute Lymphoblastic Leukemia
Journal of Korean Medical Science
;
: 630-633, 2010.
Artículo
en Inglés
| WPRIM
| ID: wpr-188010
ABSTRACT
Despite the prophylaxis and preemptive strategies using potent antiviral agents, cytomegalovirus (CMV) remains a major infectious cause of morbidity and mortality in allogeneic stem cell transplantation (SCT) recipients. Delayed immune reconstitution after SCT, such as cord blood and T-cell depleted SCT with the use of alemtuzumab, has been associated with an increased frequency of CMV disease as well as CMV reactivation. CMV disease involving central nervous system is an unusual presentation in the setting of SCT. We report a case of CMV ventriculoencephalitis after unrelated double cord blood SCT with an alemtuzumab-containing preparative regimen for Philadelphia-positive acute lymphoblastic leukemia.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Resultado Fatal
/
Infecciones por Citomegalovirus
/
Acondicionamiento Pretrasplante
/
Citomegalovirus
/
Trasplante de Células Madre de Sangre del Cordón Umbilical
/
Encefalitis
/
Leucemia-Linfoma Linfoblástico de Células Precursoras
/
Anticuerpos Monoclonales Humanizados
/
Anticuerpos Monoclonales
/
Anticuerpos Antineoplásicos
Límite:
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Journal of Korean Medical Science
Año:
2010
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS